CA2301182A1 - Cyclopeptide derivatives - Google Patents

Cyclopeptide derivatives Download PDF

Info

Publication number
CA2301182A1
CA2301182A1 CA002301182A CA2301182A CA2301182A1 CA 2301182 A1 CA2301182 A1 CA 2301182A1 CA 002301182 A CA002301182 A CA 002301182A CA 2301182 A CA2301182 A CA 2301182A CA 2301182 A1 CA2301182 A1 CA 2301182A1
Authority
CA
Canada
Prior art keywords
formula
compounds
acid
compound
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002301182A
Other languages
English (en)
French (fr)
Inventor
Gunter Holzemann
Simon Goodman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2301182A1 publication Critical patent/CA2301182A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002301182A 1997-08-23 1998-08-14 Cyclopeptide derivatives Abandoned CA2301182A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19736772.0 1997-08-23
DE19736772A DE19736772A1 (de) 1997-08-23 1997-08-23 Cyclopeptidderivate
PCT/EP1998/005161 WO1999010371A2 (de) 1997-08-23 1998-08-14 Cyclopeptidderivate als adhäsionsinhibitoren

Publications (1)

Publication Number Publication Date
CA2301182A1 true CA2301182A1 (en) 1999-03-04

Family

ID=7839977

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002301182A Abandoned CA2301182A1 (en) 1997-08-23 1998-08-14 Cyclopeptide derivatives

Country Status (18)

Country Link
EP (1) EP1007545A2 (zh)
JP (1) JP2001514186A (zh)
KR (1) KR20010022828A (zh)
CN (1) CN1267306A (zh)
AR (1) AR013650A1 (zh)
AU (1) AU734829B2 (zh)
BR (1) BR9811992A (zh)
CA (1) CA2301182A1 (zh)
DE (1) DE19736772A1 (zh)
HU (1) HUP0003500A3 (zh)
ID (1) ID23952A (zh)
NO (1) NO20000860D0 (zh)
PL (1) PL341090A1 (zh)
RU (1) RU2200166C2 (zh)
SK (1) SK2132000A3 (zh)
TW (1) TW477793B (zh)
WO (1) WO1999010371A2 (zh)
ZA (1) ZA987558B (zh)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE4415310A1 (de) * 1994-04-30 1995-11-02 Merck Patent Gmbh Cyclopeptide
JPH07316193A (ja) * 1994-05-24 1995-12-05 Asahi Glass Co Ltd ペプチド誘導体およびその用途

Also Published As

Publication number Publication date
NO20000860L (no) 2000-02-22
HUP0003500A3 (en) 2001-12-28
NO20000860D0 (no) 2000-02-22
ZA987558B (en) 1999-02-23
HUP0003500A2 (hu) 2001-02-28
PL341090A1 (en) 2001-03-26
AR013650A1 (es) 2001-01-10
AU9531998A (en) 1999-03-16
DE19736772A1 (de) 1999-02-25
AU734829B2 (en) 2001-06-21
ID23952A (id) 2000-06-08
CN1267306A (zh) 2000-09-20
TW477793B (en) 2002-03-01
BR9811992A (pt) 2000-09-05
WO1999010371A2 (de) 1999-03-04
RU2200166C2 (ru) 2003-03-10
JP2001514186A (ja) 2001-09-11
KR20010022828A (ko) 2001-03-26
WO1999010371A3 (de) 1999-05-27
EP1007545A2 (de) 2000-06-14
SK2132000A3 (en) 2000-09-12

Similar Documents

Publication Publication Date Title
US5849692A (en) Cyclic peptides containing Arg-Gly-Asp, and derivatives thereof, as adhesion inhibitors
AU717574B2 (en) Cyclic adhesion inhibitors
US6326403B1 (en) Diacylhydrazine derivatives as integrin inhibitors
AU697614B2 (en) Novel cyclopeptides for the preparation of medicaments
US6127335A (en) Cyclic adhesion inhibitors
US5705481A (en) Cyclopeptides
US6534478B1 (en) Cyclic azapeptides with angiogenic effect
US6566491B2 (en) Cyclopeptide derivatives
JPH06321988A (ja) 新規直鎖状ペプチド
AU722817B2 (en) Cyclopeptide derivatives
AU734829B2 (en) Cyclopeptide derivatives
MXPA00001728A (en) Cyclopeptide derivatives as adhesion inhibitors
CA2102447C (en) Cyclopeptides
CZ2000636A3 (cs) Derivát cyklického peptidu jakožto inhibitor adheze
CZ465899A3 (cs) Derivát cyklického azapeptidu s angiogenním působením
MXPA99011999A (en) Cyclic azapeptides with angiogenic effect
MXPA99005778A (en) Cyclic peptide derivatives
MXPA01000437A (en) Diacylhydrazine derivatives as integrin inhibitors

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued